The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM
Cancer Cell. 2003 3 (2): 185-97

PMID: 12620412 · DOI:10.1016/s1535-6108(03)00028-x

MeSH Terms (26)

ADP-Ribosylation Factors Adult Aged Aged, 80 and over Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p16 Cyclin D1 DNA-Binding Proteins Female Gene Expression Profiling Genes, Neoplasm Humans Lymphoma, Mantle-Cell Male Middle Aged Neoplasm Proteins Prognosis Protein Serine-Threonine Kinases Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger RNA, Neoplasm Survival Rate Tumor Suppressor Protein p53 Tumor Suppressor Proteins Untranslated Regions

Connections (1)

This publication is referenced by other Labnodes entities: